Differential inhibitory effects of isosorbide dinitrate and its mononitrate metabolites on platelet aggregation and thromboxane formation.

Plasma concentrations of isosorbide dinitrate and its metabolites after chronic high oral dosage in man.

Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.

Pharmacokinetics of isosorbide mononitrate.

Inhibitory effects of yuzu and its components on human platelet aggregation.

Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate.

Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.

Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression.

Effects of calcium channel blockers on platelet aggregation and thromboxane A2 formation: an in vivo double blind randomized study.

Differential effects of glycation on protein aggregation and amyloid formation.

Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.

In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.

Cluster headaches from isosorbide dinitrate.

Comparison of anti-platelet properties of molsidomine, isosorbide-5-mononitrate and placebo in healthy volunteers.

Comparison of Effects of Propofol and Isosorbide Dinitrate during Rewarming on Cardiopulmonary Bypass.

The effects of oral isosorbide 5-mononitrate on mortality following acute myocardial infarction: a multicentre study.

Action of some salicylate derivatives on in vitro platelet aggregation. Inhibitory and inhibition antagonistic effects.

Inhibitory effects of kiwifruit extract on human platelet aggregation and plasma angiotensin-converting enzyme activity.

Comparative inhibitory effects of dihydropyridines on platelet aggregation, calcium uptake and cyclic AMP concentration.

Isosorbide dinitrate in portal hypertensive patients.

Effects of nicotine on cardiac prostaglandin and platelet thromboxane synthesis.

Vasodilator properties of nitroglycerin and isosorbide dinitrate during cardiopulmonary bypass.

Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.

Relationship between pharmacokinetics and hemodynamic tolerance to isosorbide-5-mononitrate.

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.

Suggest Documents

Plasma concentrations of isosorbide dinitrate and its metabolites after chronic high oral dosage in man.

Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.

Pharmacokinetics of isosorbide mononitrate.

Inhibitory effects of yuzu and its components on human platelet aggregation.

Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate.

Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.

Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression.

Effects of calcium channel blockers on platelet aggregation and thromboxane A2 formation: an in vivo double blind randomized study.

Differential effects of glycation on protein aggregation and amyloid formation.

Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.

In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.

Cluster headaches from isosorbide dinitrate.

Comparison of anti-platelet properties of molsidomine, isosorbide-5-mononitrate and placebo in healthy volunteers.

Comparison of Effects of Propofol and Isosorbide Dinitrate during Rewarming on Cardiopulmonary Bypass.

The effects of oral isosorbide 5-mononitrate on mortality following acute myocardial infarction: a multicentre study.

Action of some salicylate derivatives on in vitro platelet aggregation. Inhibitory and inhibition antagonistic effects.

Inhibitory effects of kiwifruit extract on human platelet aggregation and plasma angiotensin-converting enzyme activity.

Comparative inhibitory effects of dihydropyridines on platelet aggregation, calcium uptake and cyclic AMP concentration.

Isosorbide dinitrate in portal hypertensive patients.

Effects of nicotine on cardiac prostaglandin and platelet thromboxane synthesis.

Vasodilator properties of nitroglycerin and isosorbide dinitrate during cardiopulmonary bypass.

Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.

Relationship between pharmacokinetics and hemodynamic tolerance to isosorbide-5-mononitrate.

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.

Differential inhibitory effects of isosorbide dinitrate and its mononitrate metabolites on platelet aggregation and thromboxane formation.

Recommend Documents

Follow Us